Case Report

Published on 19 Oct 2022

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

in Thoracic Oncology

Xiangyu Xu
Zixia Shi
Dan Fu
Depei Huang
Zheng Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1008932

2,513 views
2 citations

Original Research

Published on 19 Oct 2022

Construction of survival prediction model for elderly esophageal cancer

in Thoracic Oncology

Shuai Qie
Hongyun Shi
Fang Wang
Fangyu Liu
Jinling Gu
Xiaohui Liu
Yanhong Li
Xiaoyue Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.1008326

1,961 views
2 citations

Original Research

Published on 18 Oct 2022

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

in Thoracic Oncology

Cheng-Sen Liu
Ying-Qiu Song
Run-Ze Wang
Zheng Wang
Rong He
Ke Xu
Chen-Yu Wang
Yu Wu
Ye Wang
Xiao-fang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.991378

1,040 views

Clinical Trial

Published on 18 Oct 2022

A phase II study of buparlisib in relapsed or refractory thymomas

in Thoracic Oncology

Mohammad I. Abu Zaid
Milan Radovich
Sandra Althouse
Hao Liu
Aaron J. Spittler
Jeffrey Solzak
Sunil Badve
Patrick J. Loehrer

Frontiers in Oncology

doi 10.3389/fonc.2022.891383

2,065 views
13 citations

Case Report

Published on 18 Oct 2022

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma

in Thoracic Oncology

Liang Ge-ge
Geng Cuicui
Li Leiqiang
Tian Yongcang
Ma Jiangang
Ou Yiwen
Sun Li-zhe

Frontiers in Oncology

doi 10.3389/fonc.2022.1029679

1,608 views
4 citations

Case Report

Published on 18 Oct 2022

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy

in Thoracic Oncology

Woo Kyung Ryu
Hyungkeun Cha
Mi Hwa Park
Jung Soo Kim
Jeong-Seok Choi
Lucia Kim
Kyung-Hee Lee
Hae-Seong Nam

Frontiers in Oncology

doi 10.3389/fonc.2022.900966

1,677 views
1 citation

Original Research

Published on 17 Oct 2022

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

in Thoracic Oncology

Yin Shi
Rui Pei
Shao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.833773

2,770 views
2 citations

Original Research

Published on 17 Oct 2022

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

in Thoracic Oncology

Changqing Dong
Wanwan Cheng
Meiling Zhang
Si Li
Lele Zhao
Dongsheng Chen
Yong Qin
Mingzhe Xiao
Shencun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.992596

2,332 views
2 citations

Original Research

Published on 17 Oct 2022

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

in Thoracic Oncology

Fengling Shao
Huajie Mao
Tengling Luo
Qijun Li
Lei Xu
Yajun Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.894485

3,803 views
9 citations

Original Research

Published on 17 Oct 2022

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

in Thoracic Oncology

Stephen V. Liu
Xiaohan Hu
Yeran Li
Bin Zhao
Thomas Burke
Vamsidhar Velcheti

Frontiers in Oncology

doi 10.3389/fonc.2022.999343

4,886 views
15 citations

Case Report

Published on 17 Oct 2022

Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinoma

in Thoracic Oncology

Filipa Ferreira da Silva
Rita Barata
Inês Rolim
Catarina Carvalheiro
Nuno Gil
Marcos Pantarotto

Frontiers in Oncology

doi 10.3389/fonc.2022.1001627

1,253 views
2 citations

Case Report

Published on 17 Oct 2022

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review

in Thoracic Oncology

Dan Han
Kewei Zhao
Qin Yang
Liling Zhang
Shihong Fei

Frontiers in Oncology

doi 10.3389/fonc.2022.1016320

1,314 views
2 citations

Original Research

Published on 14 Oct 2022

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

in Thoracic Oncology

Liang Shi
Qiyi Meng
Li Tong
Hongxia Li
Yujie Dong
Chongyu Su
Zhe Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.956755

2,866 views
4 citations

Original Research

Published on 13 Oct 2022

AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels

in Thoracic Oncology

Xiuyuan Chen
Hao Xu
Qingyi Qi
Chao Sun
Jian Jin
Heng Zhao
Xun Wang
Wenhan Weng
Shaodong Wang
Xizhao Sui

Frontiers in Oncology

doi 10.3389/fonc.2022.1021084

3,033 views
8 citations

Case Report

Published on 13 Oct 2022

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation

in Thoracic Oncology

Shinkichi Takamori
Takashi Seto
Masafumi Yamaguchi
Fumihiko Kinoshita
Takatoshi Fujishita
Kensaku Ito
Ryo Toyozawa
Fumihiro Shoji
Tatsuro Okamoto

Frontiers in Oncology

doi 10.3389/fonc.2022.965741

3,342 views
8 citations

Original Research

Published on 12 Oct 2022

Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images

in Thoracic Oncology

Ri-qiang Liao
An-wei Li
Hong-hong Yan
Jun-tao Lin
Si-yang Liu
Jing-wen Wang
Jian-sheng Fang
Hong-bo Liu
Yong-he Hou
Chao Song

Frontiers in Oncology

doi 10.3389/fonc.2022.1002953

3,895 views
8 citations

Navigation group

Articles

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

Construction of survival prediction model for elderly esophageal cancer

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

A phase II study of buparlisib in relapsed or refractory thymomas

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinoma

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation

Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images